Translation, Cross-cultural Adaptation and Validation of Hindi Version of Polycystic Ovary Syndrome-quality of Life Scale (PCOSQOL-I) - A Cross-sectional study

多囊卵巢综合征生活质量量表(PCOSQOL-I)印地语版的翻译、跨文化适应和验证——一项横断面研究

阅读:2

Abstract

BACKGROUND: With specific symptomatology and clinical presentation, the validity of standard quality of life assessment scales is questionable for polycystic ovary syndrome (PCOS) women. AIM: The aim of the study was to translate and validate the Hindi version of the PCOS-related Quality of Life (PCOSQOL) scale into culturally adaptable, screening tool for Indian women with PCOS. SETTINGS AND DESIGN: A cross-sectional study was conducted in the outpatient department of a tertiary care hospital. MATERIALS AND METHODS: After standard translation and linguistic validation, modifications were done as per culturally acceptable items. After the item content validity index and scale content validity ratio testing, the preliminary tool was prepared. After pilot testing and minor modifications, the final PCOSQOL for Indian Women (PCOSQOL-I) tool was applied to 287 PCOS women to check reliability, exploratory factor analysis, uniqueness, and factor loading. STATISTICAL ANALYSIS USED: R (version 4.3.0 [2023-04-21]). RESULTS: The CVI of the 27-item Hindi tool was 0.73, 0.83, 0.70, and 0.72, respectively, for relevance, clarity, appropriateness, and necessity, thus indicating recommended content validity. A three-factor solution emerged through exploratory factor analysis with proportional variance for factors 1 (impact of PCOS), 2 (hirsutism), and 3 (infertility) as 0.22, 0.12, and 0.10, respectively. The cumulative variance was 0.22, 0.35, and 0.44, respectively. There was high internal consistency (Cronbach Alpha 0.89). On factor loadings, and dropping items with value <0.3, final 25-item PCOSQOL-I scale was developed where each item scored 0-4 with higher score indicating better quality of life. CONCLUSION: The PCOSQOL-I scale has good reliability and may be used to screen the quality of life for PCOS women. Further testing of the tool is warranted to check its competency to differentiate among PCOS women with different phenotypes.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。